Rodney Aulick - 02 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: EVP & President, WSS
Issuer ticker: XYL
Reported as of: 02 Mar 2026
Net transaction value: +$709,519
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:52:55 UTC
Prior SEC filing: 06 Jan 2026
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mike Nazario, by power of attorney for Rodney Aulick

Key filing fact

Rodney Aulick filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2026.

Key facts

This page summarizes Rodney Aulick's Form 4 filing for Xylem Inc. (XYL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 16:52.

Change

Previous filing in this sequence was filed on 06 Jan 2026.
Current net transaction value: +$709,519.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001720147 Primary reporting owner

Aulick Rodney

Relationship: EVP & President, WSS
Address: C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
Signature: /s/ Mike Nazario, by power of attorney for Rodney Aulick
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $0
Shares: +1,610
Change %: +2.2%
Price: $0.000000
Shares after: 74,155
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1, F2

XYL transaction

Common Stock

Tax liability

Transaction value: $30,697
Shares: -238
Change %: -0.32%
Price: $128.98
Shares after: 73,917
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Non-Qualified Stock Options (Right to Buy)

Award

Transaction value: $740,216
Shares: +5,739
Change %
Price: $128.98
Shares after: 5,739
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,739
Exercise price: $128.98
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.

Footnote F2

Includes additional shares due to dividend reinvestment.

Footnote F3

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Footnote F4

Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.